Evidence mapPaperPMID 42201611Full record

ArticleStem cell reviews and reports2026

Oxygen-generating Microparticles Enhance Viability and Functionality of Human Pluripotent Stem Cell-derived Cardiomyocytes for Myocardial Infarction Therapy.

Xingyu He, Suchandrima Dutta, Darshini Desai, Sheng Zhong, William Liu, Sophie Chen, Wei Huang, Waqas Ahmad, Jialiang Liang, Yigang Wang

Abstract read
In one paragraph

Article in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xingyu He *Department of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA.
Suchandrima Dutta *Department of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA.
Darshini DesaiDepartment of Pharmacology, Physiology and Neurobiology, College of Medicine, University of Cincinnati, Cincinnati, OH, 45267, USA.
Sheng ZhongDepartment of Cancer Biology, College of Medicine, University of Cincinnati, Cincinnati, OH, 45267, USA.
William LiuDivision of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, 45229, USA.
Sophie ChenDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA.
Wei HuangDepartment of Internal Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH, 45267, USA.
Waqas AhmadDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA.
Jialiang LiangDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA. liangjl@ucmail.uc.edu.
Yigang WangDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA. yi-gang.wang@uc.edu.

Funding

Engineering RNA biodevices for precise modulation of fibroblasts to boost cardiac reprogrammingR21HL177541 · UNIVERSITY OF CINCINNATI · 2025 to 2025
$243k
American Heart Association 26PRE1565814American Heart Association 968781American Heart Association-American Stroke Association 968781NHLBI NIH HHS R01 HL157456NHLBI NIH HHS R21 HL177541NIH HHS R01HL157456NIH HHS R21HL177541
6 · The paper itself

Abstract

backgroundHuman induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) represent a promising therapy for myocardial infarction (MI), but their survival is severely limited by the hypoxic infarct environment. The optimal oxygen levels required to maintain the viability and functionality of hiPSC-CMs remain poorly defined. This study aimed to develop a controlled oxygen-delivery system to support engineered heart tissue (EHT) for cardiac regeneration.

methodsOxygen-generating particles (OGPs) were engineered using peroxide (sodium percarbonate) and antioxidant (β-carotene (βCAR)) components encapsulated in PLGA microparticles. The effects of OGPs on hiPSC-CMs were evaluated through oxidative stress assays, cell viability analysis, and contractility measurements. RNA-seq was performed to investigate gene expression changes in hiPSC-CMs in response to OGPs and hypoxic stress. hiPSC-CMs combined with OGPs were encapsulated in a 3D hydrogel to generate oxygen-releasing engineered heart tissue (OR-EHT), which was implanted into infarcted hearts of immunodeficient mice. Cardiac function was assessed by echocardiography, and cell engraftment was evaluated using immunostaining.

resultsOGPs provided controlled oxygen release for up to 22 days. Inclusion of βCAR minimized OGP-induced oxidative stress, preserved mitochondrial membrane potential, and maintained cell viability. OGP treatment enhanced calcium signaling and contractility in hiPSC-CMs. Transcriptomic analysis revealed that genes associated with CM maturation and contractile function were upregulated following OGP pretreatment. In addition, OGP pretreatment significantly reduced HIF-1α expression, decreased mitochondrial fragmentation, and improved survival. RNA-seq further demonstrated activation of oxygen-responsive metabolic pathways that facilitated cellular adaptation to hypoxic stress. In vivo, OR-EHT implantation for 6 weeks improved cardiac function, increased ejection fraction, reduced ventricular remodeling, and decreased infarct size compared with EHT without OGPs. Moreover, OGP incorporation significantly enhanced engraftment and survival of transplanted hiPSC-CMs and supported features consistent with early structural integration with host myocardium.

conclusionOGP-mediated oxygen delivery offers a promising strategy for oxidative preconditioning and significantly improves the regenerative efficacy of hiPSC-CM-based cardiac therapies.

Indexed as

Cell-Derived MicroparticlesInduced Pluripotent Stem CellsMyocardial InfarctionMyocytes, CardiacOxygenAnimalsCell DifferentiationCell SurvivalHumansMiceOxidative StressTissue EngineeringOxygenEngineered heart tissueHiPSC-derived cardiomyocytesHypoxiaMyocardial infarctionOxygen-generating microparticles

Identifiers

PMID42201611
PMCPMC13354643

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.